BIO India International Conference Set to Start in September
The Biotechnology Industry Organizations annual BIO India International Conference is all set to start on September 12 and 13 at […]
Tags: Advisor, BIO India International, biology, biotechnology, Business/Finance, Health/Medical/Pharmaceuticals, Healthcare sector, Human Genome Sciences Inc., India, Maryland, mumbai, Panchapagesa Murali, pharmaceutical, President, president and chief utive officer, Prime Minister, Sam Pitroda, Thomas Watkins
Marking the Biomarkers
In order to truly reap the benefits in clinical practice and shorten the warm-up period, education and awareness are most […]
Aim for Excellence
Dr Anil Mishra, Medical Director & Interventional Cardiologist, BM Birla Heart Research Centre Recently, Quadripolar technology was launched in India, and […]
Cardiology in Action
I consider myself lucky to be living in a world where lots of new things are happening in the field […]
Awakening Senses
Dr Animesh Arya, Senior Chest Physician, Specialist in Allergy, Sleep and Critical Care, Centre for Sleep, New Delhi Technology is revolutionising […]
There is a huge potential for mHealth in India
Dr Arun Varma Vice President & Head Health Initiatives, IL&FS Education Technology ServiceGive us a brief overview of IL& FS […]
nContact EPi-Sense device receives CE mark
nContact has received CE mark approval for its fourth generation EPi-Sense guided-coagulation device with VisiTrax for the treatment of cardiac arrhythmias, including atrial fibrillation.
New treatment for prostate avoids sexual dysfunction
A new radiology treatment that limits blood flowing to a man
Breakthrough in medical device interoperability
Cambridge Consultants announced recently the first demonstration of the emerging industry standards for medical device interoperability. The ‘Vena’ platform is a breakthrough software solution on a single chip that allows medical devices such as blood pressure monitors to transmit data wirelessly.
Molecular Markers to Predict Prostate Cancer Aggressiveness
Researchers at Dana-Farber Cancer Institute in the US have identified a signature of four molecular markers that can be used to predict if an existing prostate cancer is likely to remain dormant or spread to other parts of the body.
Build security, end blood scarcity : Dr Rajesh Gopal, Managing Director, Gujarat State AIDS Control Society
[This article was published in the October 2010 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Well-coordinated chains of mother banks and storage centres, supported by NGOs and altruistic donors, is the way to go
Local Innovations, Global Opportunities
V Raja, President & CEO (South Asia), GE Healthcare talks with eHEALTH about achievements and initiatives of his company in India, […]
